Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Children’s book tells KC entrepreneurs’ stories; challenging traditional pathways to success
Christle Reed wants Kansas City’s next wave of potential business builders to know they needn’t be bound to a mainstream plot line for wealth and happiness, the entrepreneur-turned-author shared. Her new children’s book about more than a dozen local entrepreneurs could help rewrite that narrative. “College isn’t the only way to success for kids,” she…
Help from above: Why protecting satellites from cyber attacks could hold key to adapting to climate change
Humans must responsibly rise to the occasion as Earth’s climate changes, Charles Beames said, detailing the role well-protected satellites and space systems can play in putting life-preserving solutions into orbit. “Space systems are one of the keys to the future, our future, of dealing with the changing climate and our adaptation,” said Beames, aerospace expert and…
In the field: Industry-specific, hands-free voice tech helps ‘hero up’ data collecting workers
After years of research, Bruce Rasa and his team identified a consistent pain point for field workers: capturing data on-the-go and looping it back to their headquarters. They need a co-pilot, he said, noting the role played by KC-based Dexer (formerly AgVoice), agriculture’s first handsfree data capture service to help cross-industry specialists create records —…
New city flag designed for KC’s now (and tomorrow): Here’s where you’ll see it flying first
Kansas City is ushering in an era of growth and development, Jared Horman said, and the unveiling of a new municipal flag is just the way to recognize this new chapter. “The timing feels particularly exciting with the Chiefs headed to the Super Bowl, the opening of the new terminal at the airport and the…